Need help or have questions about your order? Call 510-991-8265Questions about your order? Call 510-991-8265

Sign InShop GLPs
Shop GLPs

Is CJC-1295 Legal in Georgia? How to Access It Legally

By
Published Updated Last reviewed
10 linked public sourcesEditorial, sourcing, and corrections policy

At a glance

  • FDA approval / not approved; FDA found no approved product containing any form of CJC-1295 in 12 countries and none authorized by the European Medicines Agency [1]
  • FDA list for state-licensed pharmacies and physicians / CJC-1295 is not on it [2]
  • FDA list for outsourcing facilities / CJC-1295 is not on it [3]
  • Advisory committee, December 2024 / voted against the free base, the acetate and each of the three DAC forms [5]
  • Sport / prohibited at all times by WADA, in and out of competition [6]

What CJC-1295 is

CJC-1295 is an investigational long-acting analogue of growth hormone-releasing hormone, developed by ConjuChem Biotechnologies of Montreal and first described in 2005 [1][7]. FDA describes two forms: a 29-amino-acid GHRH analogue, and CJC-1295 DAC, the same peptide with an extra maleimidopropionic acid-lysine unit that lets it bind blood albumin and last much longer [1]. After a single subcutaneous injection of the DAC form in healthy adults, the estimated half-life was 5.8 to 8.1 days [8].

What FDA documents

FDA found no approved product containing any form of CJC-1295 in Australia, Belgium, Canada, Denmark, France, Germany, Ireland, Italy, Japan, Norway, Spain or the United Kingdom, and none authorized by the European Medicines Agency [1].

CJC-1295 is in none of the three categories on FDA's list for state-licensed pharmacies and physicians (updated May 14, 2026) and is not on FDA's list for outsourcing facilities (updated March 21, 2025). It is not a component of an FDA-approved drug and has no USP monograph, so FDA's category 1 policy does not apply to it [2][3].

On FDA's page about bulk substances that may raise significant safety risks, CJC-1295 sits in the 'nominated but withdrawn' table: it was in category 2 but came off because the nominators withdrew their nominations. FDA's stated concerns remain posted: possible immunogenicity for certain routes, impurity and characterization problems, serious adverse events including increased heart rate and systemic vasodilatory reaction, and limited clinical data [9].

On December 4, 2024 FDA's Pharmacy Compounding Advisory Committee voted 0 yes, 13 no on CJC-1295 free base; 1 yes, 12 no on CJC-1295 acetate; and 0 yes, 13 no on each of the three DAC forms, after FDA's reviewers proposed that none be added to the pharmacy bulks list [5].

HHS's October 2026 draft enforcement-discretion policy names six peptides (BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500), and CJC-1295 is not one of them. No FDA or HHS action allowing compounding of CJC-1295 has been identified [4].

Does Georgia law change the answer?

No Georgia-specific rule addressing CJC-1295 was identified. The federal findings above do not settle whether buying a particular vial, or using another access route, is legal in Georgia.

What is sold online

FDA noted that CJC-1295 products sold online are mostly labeled 'research use only', including blends with ipamorelin and GHRPs, and that CJC-1295 has been found in illicit sports use [1]. Research-use-only products are not FDA-approved drugs [1]. There is no FDA-approved dose [1].

Athletes

WADA's 2026 Prohibited List names CJC-1295 and CJC-1293 in S2.2.4 as growth hormone-releasing hormone analogues, prohibited at all times, in and out of competition [6]. The 2027 List names CJC-1295 as well [10].

Frequently asked questions

Is CJC-1295 legal in Georgia?
CJC-1295 is not FDA-approved. FDA found no approved product containing it in the 12 countries it searched and none authorized by the European Medicines Agency, and the peptide is absent from both of FDA's compounding bulk-substance lists, so no approved or listed supply is documented [1][2][3].
Can a Georgia doctor prescribe CJC-1295 and have a pharmacy fill it?
A prescription does not create an approved product. CJC-1295 is absent from FDA's list for state-licensed pharmacies and physicians and from its list for outsourcing facilities, FDA's category 1 policy does not apply to it, and the advisory committee voted 0 yes and 13 no on the free base in December 2024 [2][3][5].
Is a research-use-only vial of CJC-1295 legal to buy?
FDA says research-use-only products are not FDA-approved drugs, and it noted that most CJC-1295 sold online carries that label [1].
Does the difference between CJC-1295 with and without DAC change the federal status?
Not to what FDA has documented. No form is on either bulk-substance list, and the advisory committee voted against the free base, the acetate and each of the three DAC forms [2][3][5]. The published human studies all tested the DAC form in healthy volunteers [1].
Can athletes use CJC-1295?
WADA names CJC-1295 in S2.2.4 of its 2026 and 2027 Prohibited Lists and prohibits it at all times, in and out of competition [6][10].

References

  1. U.S. Food and Drug Administration. U.S. Food and Drug Administration
  2. U.S. Food and Drug Administration. U.S. Food and Drug Administration
  3. U.S. Food and Drug Administration. U.S. Food and Drug Administration
  4. Official web page. Official web page
  5. U.S. Food and Drug Administration. U.S. Food and Drug Administration
  6. World Anti-Doping Agency. World Anti-Doping Agency
  7. Jetté L, Léger R, Thibaudeau K, Benquet C, Robitaille M, Pellerin I, et al. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. 2005;146(7):3052-8. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog
  8. Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799-805. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
  9. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA
  10. World Anti-Doping Agency. World Anti-Doping Agency
Evidence overview for Is CJC-1295 Legal in Georgia? How to Access It Legally